Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 839003

Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy


Petrić Miše, Branka; Boraska Jelavić, Tihana; Strikić, Ante; Hrepić, Dario; Tomić, Krešimir; Hamm, W.; Tomić, Snježana; Prskalo, Tomislav; Vrdoljak, Eduard
Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy // International journal of gynecological cancer, 25 (2015), 2; 315-319 doi:10.1097/IGC.0000000000000336 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 839003 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy

Autori
Petrić Miše, Branka ; Boraska Jelavić, Tihana ; Strikić, Ante ; Hrepić, Dario ; Tomić, Krešimir ; Hamm, W. ; Tomić, Snježana ; Prskalo, Tomislav ; Vrdoljak, Eduard

Izvornik
International journal of gynecological cancer (1048-891X) 25 (2015), 2; 315-319

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
advanced cervical cancer ; concomitant chemobrachyradiotherapy ; ifosfamide ; cisplatin

Sažetak
OBJECTIVES: Locally advanced cervical cancer (LACC) is one of the leading health problems of the developing countries. We present long-term outcomes of treatment with a concomitant chemobrachyradiotherapy followed by consolidation chemotherapy regimen. MATERIALS AND METHODS: We treated 118 patients with LACC (International Federation of Gynecology and Obstetrics stages IB2-IVA) with external radiotherapy (50 Gy in 25 fractions) and concomitant chemobrachyradiotherapy (low-dose rate). Chemotherapy was applied during brachyradiotherapy (cisplatin on day 1 in combination with 24-hour infusion of ifosfamide and mesna uroprotection). Four cycles of consolidation chemotherapy were given starting 4 weeks after the second concomitant chemobrachyradiotherapy cycle. RESULTS: After median follow-up period of 99.3 months, we observed acceptable acute and late toxicity, local control rate of 97.5%, and an overall survival of 74.6% at 96 months. CONCLUSIONS: Chemobrachyradiotherapy regimen followed by consolidation chemotherapy described in this article is a valuable treatment option for LACC.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
KBC Split

Poveznice na cjeloviti tekst rada:

doi journals.lww.com

Citiraj ovu publikaciju:

Petrić Miše, Branka; Boraska Jelavić, Tihana; Strikić, Ante; Hrepić, Dario; Tomić, Krešimir; Hamm, W.; Tomić, Snježana; Prskalo, Tomislav; Vrdoljak, Eduard
Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy // International journal of gynecological cancer, 25 (2015), 2; 315-319 doi:10.1097/IGC.0000000000000336 (međunarodna recenzija, članak, znanstveni)
Petrić Miše, B., Boraska Jelavić, T., Strikić, A., Hrepić, D., Tomić, K., Hamm, W., Tomić, S., Prskalo, T. & Vrdoljak, E. (2015) Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy. International journal of gynecological cancer, 25 (2), 315-319 doi:10.1097/IGC.0000000000000336.
@article{article, author = {Petri\'{c} Mi\v{s}e, Branka and Boraska Jelavi\'{c}, Tihana and Striki\'{c}, Ante and Hrepi\'{c}, Dario and Tomi\'{c}, Kre\v{s}imir and Hamm, W. and Tomi\'{c}, Snje\v{z}ana and Prskalo, Tomislav and Vrdoljak, Eduard}, year = {2015}, pages = {315-319}, DOI = {10.1097/IGC.0000000000000336}, keywords = {advanced cervical cancer, concomitant chemobrachyradiotherapy, ifosfamide, cisplatin}, journal = {International journal of gynecological cancer}, doi = {10.1097/IGC.0000000000000336}, volume = {25}, number = {2}, issn = {1048-891X}, title = {Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy}, keyword = {advanced cervical cancer, concomitant chemobrachyradiotherapy, ifosfamide, cisplatin} }
@article{article, author = {Petri\'{c} Mi\v{s}e, Branka and Boraska Jelavi\'{c}, Tihana and Striki\'{c}, Ante and Hrepi\'{c}, Dario and Tomi\'{c}, Kre\v{s}imir and Hamm, W. and Tomi\'{c}, Snje\v{z}ana and Prskalo, Tomislav and Vrdoljak, Eduard}, year = {2015}, pages = {315-319}, DOI = {10.1097/IGC.0000000000000336}, keywords = {advanced cervical cancer, concomitant chemobrachyradiotherapy, ifosfamide, cisplatin}, journal = {International journal of gynecological cancer}, doi = {10.1097/IGC.0000000000000336}, volume = {25}, number = {2}, issn = {1048-891X}, title = {Long follow-up of patients with locally advanced cervical cancer treated with concomitant chemobrachyradiotherapy with cisplatin and ifosfamide followed by consolidation chemotherapy}, keyword = {advanced cervical cancer, concomitant chemobrachyradiotherapy, ifosfamide, cisplatin} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font